HOME >> MEDICINE >> NEWS
'Camera pill' promising for diagnosis of small bowel disease

r malformations and other small bowel abnormalities than ingested barium exams or CT, the current diagnostic standards for small intestine disorders.

The Mayo study reviewed data on the first 52 patients to undergo CE at the clinic following a barium study or CT for unexplained gastrointestinal bleeding, inflammatory bowel disease or chronic abdominal pain. Forty patients received a barium study and CE. Of those, CE helped radiologists detect abnormalities in 22 patients (55 percent), while barium studies yielded abnormal results in only 1 patient (3 percent). Nineteen patients underwent CT examination as well as CE. Of those, CE helped radiologists detect abnormalities in 12 patients (63 percent), while CT yielded abnormal results in 4 patients (21 percent).

"We wanted to see what we were missing or not missing with standard radiology techniques," said Dr. Hara, principal author of the study. "The information we are gaining from CE will allow us to improve our use of CT for better diagnoses and determine when to pair the two technologies."


'"/>

Contact: Maureen Morley
mmorley@rsna.org
630-590-7754
Radiological Society of North America
6-Jan-2004


Page: 1 2

Related medicine news :

1. Virtual stomach reveals pills path
2. Newest version of the pill confers same stroke risk as old pill
3. Another look finds promising proteomics test is not biologically plausible
4. Inflammatory cells highly promising target in NF 1
5. Drug treatment promising for halting Huntingtons-related nerve death
6. Triple-drug therapy promising against African HIV subtype
7. Mayo Clinic researchers announce promising next generation treatments for multiple myeloma
8. Outpatient lung cancer procedure promising for inoperable disease
9. PET scanning promising in diagnosing cancer-related neurological disorders
10. Preliminary results are promising in Alzheimers gene therapy trial
11. Fertility herbal supplement sprouts promising results in Stanford pilot study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Camera pill promising for diagnosis small bowel disease

(Date:5/20/2013)... The Multiple System Atrophy Coalition (formerly ... its new Multiple System Atrophy (MSA) Research Grant ... MSA Coalition’s grass roots fundraising has grown and enabled ... support to now include education, advocacy and research funding ... by The Coalition go directly into a dedicated MSA ...
(Date:5/20/2013)... Gilman Law LLP, a leading pharmacy law and ... troubled by a new study that reveals that pancreatic ... diabetes drugs are growing. The analysis, conducted by ... 71 Byetta pancreatic cancer reports had been made to ... June 30, 2012. Overall, Byetta and other ...
(Date:5/20/2013)... Sporturf, an international manufacturer and builder of ... the Midwest with the opening of the company’s third ... Midwest is under the leadership of President Craig Shonk, ... , “This strategic move opens up a ... noted Shonk. “Bringing an ISO manufacturer and a Midwest-based ...
(Date:5/20/2013)... Plains, NY (PRWEB) May 20, 2013 ... firm of Levy Phillips & Konigsberg LLP ... Street in White Plains, New York. LPK will better ... in the Hudson Valley, including Westchester, Putnam, Rockland, Orange, ... helping families affected by asbestos-related diseases throughout New York, ...
(Date:5/20/2013)... VA (PRWEB) May 20, 2013 Orthopaedic ... successfully performed a procedure using SpineFrontier’s FacetFuse Screw System ... System. The operation took place on Tuesday, April ... Newport News, VA. The surgery was a facet ... year-old, female patient. , Dr. Carlson described the case, ...
Breaking Medicine News(10 mins):Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 2Health News:Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports 3Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 2Health News:Dr. Jeffrey Carlson Successfully Performs Procedure Using SpineFrontier’s Less Exposure Surgery Technology: FacetFuse 3
(Date:5/20/2013)... 2013 Sequent Medical, Inc. announced today that ... Layer") family of WEB ® Aneurysm Embolization Devices, ... models in select neurovascular centers in Europe.  The SL ... will enable physicians to treat a broader range of ... configurations are made possible by further advancement of Sequent ...
(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...
(Date:5/20/2013)... , May 20, 2013   Life Technologies ... that its Applied Biosystems™ 3500 Dx and 3500xL Dx ... for Protection against Health Risks in Mexico ... major extension of Life Technologies, capabilities to serve the ... with Sanger -based solutions.  ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3
Cached News: